A randomized phase 2 study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy Meeting Abstract


Authors: McArthur, H.; Comen, E.; Bryce, Y.; Solomon, S. B.; Leal, J.; Rodine, M.; Abaya, C. D.; Patil, S.; Page, D.; Norton, L.
Abstract Title: A randomized phase 2 study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy
Meeting Title: 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 80
Issue: 4 Suppl.
Meeting Dates: 2019 Dec 10-14
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2020-02-01
Language: English
ACCESSION: WOS:000527012500073
DOI: 10.1158/1538-7445.Sabcs19-ot1-01-04
PROVIDER: wos
Notes: Meeting Abstract: OT1-01-04 -- Sujata Patel's first name is misspelled on the publisher's record -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sujata Patil
    511 Patil
  2. Larry Norton
    758 Norton
  3. Elizabeth Comen
    72 Comen
  4. Stephen Solomon
    424 Solomon
  5. Micaela Ariel Henrich
    11 Henrich
  6. Yolanda Bryce
    56 Bryce